190 related articles for article (PubMed ID: 6143765)
1. The combined alpha- and beta-adrenergic blocker labetalol and propranolol in the treatment of high blood pressure: similarities and differences.
Weber MA; Drayer JI; Kaufman CA
J Clin Pharmacol; 1984; 24(2-3):103-12. PubMed ID: 6143765
[TBL] [Abstract][Full Text] [Related]
2. Combined labetalol plus flunarizine treatment for arterial hypertension.
Bonavita E
Int J Clin Pharmacol Res; 1984; 4(6):475-80. PubMed ID: 6152439
[TBL] [Abstract][Full Text] [Related]
3. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
[TBL] [Abstract][Full Text] [Related]
4. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
5. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
Rosei EA; Fraser R; Morton JJ; Brown JJ; Lever AF; Robertson JI; Trust PM
Am Heart J; 1977 Jan; 93(1):124-5. PubMed ID: 12654
[No Abstract] [Full Text] [Related]
6. Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI; Trust PM
Aust N Z J Med; 1976 Aug; 6(3 Suppl):83-8. PubMed ID: 14627
[TBL] [Abstract][Full Text] [Related]
7. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
Salvetti A; Pedrinelli R; Sassano P; Arzilli F
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():401s-404s. PubMed ID: 396086
[TBL] [Abstract][Full Text] [Related]
8. Labetalol in the treatment of severe essential hypertension: relationship between arterial blood pressure, plasma catecholamines, plasma renin activity, plasma aldosterone and body weight.
Kornerup HJ; Pedersen EB; Christensen NJ; Pedersen A; Pedersen G
Acta Med Scand Suppl; 1979; 625():59-64. PubMed ID: 34981
[No Abstract] [Full Text] [Related]
9. Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
Hanna W; Grell GA
South Med J; 1980 May; 73(5):653-4. PubMed ID: 6103586
[No Abstract] [Full Text] [Related]
10. Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.
Milne BJ; Logan AG
Can Med Assoc J; 1980 Nov; 123(10):1013-6. PubMed ID: 6256045
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravenous labetalol on blood pressure, angiotensin II and aldosterone in hypertension: comparison with propranolol.
Rosei EA; Trust PM; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
Clin Sci Mol Med Suppl; 1976 Dec; 3():497s-499s. PubMed ID: 1071671
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological effects of labetalol in man.
Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
14. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
Martinand A; Lardoux H; Corvol P; Milliez P
Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
[TBL] [Abstract][Full Text] [Related]
15. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
Pugsley DJ; Nassim M; Armstrong BK; Beilin L
Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
[TBL] [Abstract][Full Text] [Related]
16. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
17. Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
Kubik MM; Coote JH
Eur J Clin Pharmacol; 1984; 26(1):1-6. PubMed ID: 6143666
[TBL] [Abstract][Full Text] [Related]
18. Response of the systemic and pulmonary circulation to alpha- and beta-receptor blockade (labetalol) at rest and during exercise in hypertensive patients.
Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
Circulation; 1979 Dec; 60(6):1214-7. PubMed ID: 40708
[No Abstract] [Full Text] [Related]
19. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
20. [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension].
Smirnov GB
Kardiologiia; 1986 Mar; 26(3):33-6. PubMed ID: 2872358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
